Expression of epidermal growth factor receptor (EGFR) in colorectal cancer: An immunohistochemical study

This publication has 17 references indexed in Scilit:

• The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
  BMC Cancer, 2013
• Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis
  Virchows Archiv, 2013
• Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system
  OncoTargets and Therapy, 2013
• HER2 testing in gastric cancer: a practical approach
  Laboratory Investigation, 2012
• The pattern of epidermal growth factor receptor variation with disease progression and aggressiveness in colorectal cancer depends on tumor location
  Oncology Letters, 2012
• Expression of Membranous Epidermal Growth Factor Receptor in Colorectal Adenocarcinoma and It ’ s Correlation with Clinicopathological Features
  Pakistan Journal of Biological Sciences, 2011
• A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy
  British Journal of Cancer, 2007
• Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives
  Annals of Oncology, 2005
• Immunohistochemical Detection of EGFR in Paraffin-embedded Tumor Tissues
  Journal of Histochemistry & Cytochemistry, 2004
• Expression of Epidermal Growth Factor (EGF) and Epidermal Growth Factor Receptor (EGFR) in Gastric and Colorectal Carcinomas1
  Pathology - Research and Practice, 1993